Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 679.55 INR
Change Today +7.65 / 1.14%
Volume 1.3M
CIPLA On Other Exchanges
Natl India
As of 7:06 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

cipla ltd (CIPLA) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/10/15 - 752.85
52 Week Low
08/8/14 - 430.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CIPLA LTD (CIPLA)

Related News

No related news articles were found.

cipla ltd (CIPLA) Related Businessweek News

No Related Businessweek News Found

cipla ltd (CIPLA) Details

Cipla Limited manufactures and sells pharmaceutical and personal care products in India. It offers active pharmaceutical ingredients; and formulations in therapeutic areas, such as allergy, analgesic, anti-malarial, anti-infectives, cardiology, dermatology and cosmeceuticals, diabetology, gastroenterology, HIV-AIDS, hormones and steroids, iron chelators, musculoskeletal, neuropsychiatry, oncology, respiratory, urology, and women’s health, as well as nutritional and ophthalmic products. The company also provides veterinary products for various animals, including companion, equine, general care, livestock, and poultry. In addition, it offers inhaled medication and devices comprising dry powder inhalers, metered-dose inhalers, spacers and related devices, nasal sprays, nebulizers, and inhalation accessory devices. The company also exports raw materials, intermediates, prescription drugs, over-the-counter drugs, and veterinary products to approximately 170 countries worldwide. Cipla Limited was founded in 1935 and is based in Mumbai, India.

Founded in 1935

cipla ltd (CIPLA) Top Compensated Officers

Global Chief Executive Officer, Managing Dire...
Total Annual Compensation: 54.4M
Whole-Time Director, Member of Mergers & Acqu...
Total Annual Compensation: 12.0M
Chief Compliance Officer and Company Secretar...
Total Annual Compensation: 9.5M
Compensation as of Fiscal Year 2015.

cipla ltd (CIPLA) Key Developments

Cipla Limited, Board Meeting, Jul 20, 2015

Cipla Limited, Board Meeting, Jul 20, 2015. Agenda: To approve a potential investment by FIL Capital Investments (Mauritius) II Limited, or any of its affiliate in a wholly owned subsidiary of Cipla Limited (proposed to be incorporated) to whom Cipla will be divesting its consumer healthcare business on a going-concern basis.

Cipla Limited Appoints Samina Vaziralli as an Additional Director and Whole-Time Director, Effective from July 10, 2015

Cipla Limited has announced that the Board of Directors of the Company at its meeting held on July 9, 2015 has appointed Mrs. Samina Vaziralli as an Additional Director and Whole-time Director designated as "Executive Director" with effect from July 10, 2015. The Company is seeking approval of shareholders at the ensuing Annual General Meeting.

Cipla Limited, Board Meeting, Jul 09, 2015

Cipla Limited, Board Meeting, Jul 09, 2015. Agenda: To appoint Mrs. Samina Vaziralli as an Additional Director and Whole-time Director designated as "Executive Director" with effect from July 10, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CIPLA:IN 679.55 INR +7.65

CIPLA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aurobindo Pharma Ltd 731.15 INR +6.00
Cadila Healthcare Ltd 1,879 INR -44.70
Divi's Laboratories Ltd 1,908 INR -6.70
Piramal Enterprises Ltd 928.65 INR +39.75
Torrent Pharmaceuticals Ltd 1,421 INR +23.90
View Industry Companies

Industry Analysis


Industry Average

Valuation CIPLA Industry Range
Price/Earnings 44.4x
Price/Sales 4.8x
Price/Book 4.8x
Price/Cash Flow 31.0x
TEV/Sales 4.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CIPLA LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at